Computational centrosomics: An approach to understand the dynamic behaviour of centrosome

Gene

Volumn 511, Issue 1, 2012, Pages 125-126

  Kumar, Ambuj ^a   Purohit, Rituraj ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Centrosome; In silico molecular modelling; Molecular dynamics simulation

Indexed keywords

AURORA A KINASE; GENOMIC DNA;

ALGORITHM; CELL CYCLE PROGRESSION; CENTROSOME; GENE EXPRESSION; GENE MUTATION; GENETIC RISK; LETTER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CENTROSOME; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; HUMANS; NEOPLASMS;

EID: 84867629652     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.040     Document Type: Letter

References (23)

1. Bibby R.A., et al. A cancer associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2. J. Biol. Chem. 2009, 284:33177-33184.
2. D'Assoro A.B., Lingle W.L., Salisbury J.L. Centrosome amplification and the development of cancer. Oncogene 2002, 21:6146-6153.
3. Dotan E., et al. Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer. Br. J. Cancer 2012, 106:748-755.
4. Gergely F., Basto R. Multiple centrosomes: together they stand, divided they fall. Genes Dev. 2008, 22:2291-2296.
5. Inoda S., et al. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells. Am. J. Pathol. 2011, 178(4):1805-1813. (2011 Apr).
6. Kawamura, et al. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur. Urol. 2003, 43:505-515.
7. Kumar A., Purohit R. Computational investigation of pathogenic nsSNPs in CEP63 protein. Gene 2012, 503:75-82.
8. Kumar, A., Purohit, R., in press. Computational screening and molecular dynamics simulation of disease associated nsSNPs in CENP-E. Mutat. Res. Fundam. Mol. Mech. Mutagen. http://dx.doi.org/10.1016/j.mrfmmm.2012.08.005.
9. Mori D., et al. NDEL1 phosphorylation by Aurora-A kinase is essential for centrosomal maturation, separation, and TACC3 recruitment. Mol. Cell. Biol. 2007, 27:352-367.
10. Pujana M.A., et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet. 2007, 39:1338-1349.
11. Purohit R., Sethumadhavan R. Structural basis for the resilience of Darunavir (TMC114) resistance major flap mutations of HIV-1 protease. Interdiscip. Sci. 2009, 1:320-328.
12. Purohit R., et al. Studies on flexibility and binding affinity of Asp25 of HIV-1 protease mutants. Int. J. Biol. Macromol. 2008, 42:386-391.
13. Purohit R., Rajendran V., Sethumadhavan R. Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis. J. Mol. Model. 2011, 17:869-877.
14. Purohit R., Rajendran V., Sethumadhavan R. Studies on adaptability of binding residues and flap region of TMC-114 resistance HIV-1 protease mutants. J. Biomol. Struct. Dyn. 2011, 29(1):137-152.
15. Rajendran V., Purohit R., Sethumadhavan R. In silico investigation of molecular mechanism of laminopathy cause by a point mutation (R482W) in lamin A/C protein. Amino Acids 2012, 43:603-615.
16. Shiraishi T., et al. Cancer/testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy. J. Transl. Med. 2011, 9:153.
17. Snape K., et al. Mutations in CEP57 cause mosaic variegated aneuploidy syndrome. Nat. Genet. 2011, 43:527-529.
18. Tao S., et al. A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants. Carcinogenesis 2012, 33:598-603.
19. Tomoda T., et al. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study. J. Gastroenterol. Hepatol. 2012, 27:797-804.
20. Wang Y., et al. Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy. Mol. Cancer 2009, 8:8.
21. Waseem A., Ali M., Odell E.W., Fortune F., Teh M.T. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma. Oral Oncol. 2010, 46:536-542.
22. Yang H., Ou C.C., Feldman R.I., Nicosia S.V., Kruk P.A., Cheng J.Q. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breastepithelial cells. Cancer Res. 2004, 64:463-467.
23. Zyss D., Gergely F. Centrosome function in cancer: guilty or innocent?. Trends Cell Biol. 2009, 19:334-346.